4//SEC Filing
HealthCare Ventures IX, L.P. 4
Accession 0001104659-21-021029
CIK 0001509745other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 9:57 PM ET
Size
11.2 KB
Accession
0001104659-21-021029
Insider Transaction Report
Form 4
HealthCare Ventures IX, L.P.
10% Owner
Transactions
- Other
Warrant (Right to Buy)
2021-02-09−571,428→ 0 totalExercise: $1.95From: 2019-02-05Exp: 2026-02-05→ Common Stock, $0.001 par value per share (571,428 underlying)
Healthcare Partners IX, L.P.
10% Owner
Transactions
- Other
Warrant (Right to Buy)
2021-02-09−571,428→ 0 totalExercise: $1.95From: 2019-02-05Exp: 2026-02-05→ Common Stock, $0.001 par value per share (571,428 underlying)
Healthcare Partners IX, LLC
10% Owner
Transactions
- Other
Warrant (Right to Buy)
2021-02-09−571,428→ 0 totalExercise: $1.95From: 2019-02-05Exp: 2026-02-05→ Common Stock, $0.001 par value per share (571,428 underlying)
Footnotes (3)
- [F1]On February 9, 2020, HealthCare Ventures IX, L.P. ("HCVIX") transferred, for no consideration, all 571,428 warrants to purchase common stock it held (the "Transfer") to the limited partners of HCVIX on a pro rata basis. The term of HCVIX expired on December 31, 2020, at which time HCVIX entered into liquidation. The process of liquidating HCVIX, including the distribution of marketable and non-marketable securities, has commenced in 2021, and HealthCare Partners IX, L.P. ("HCPIX"), the General Partner of HCVIX, as liquidator, will use its best efforts to complete the orderly liquidation of HCVIX.
- [F2]These warrants were owned directly by HCVIX. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor (collectively, the "HCVIX Directors") are the Managing Directors of HealthCare Partners IX, LLC ("HCPIX LLC"), which is the General Partner of HCPIX, which is the General Partner of HCVIX. Each of the HCVIX Directors, HCPIX LLC and HCPIX indirectly beneficially owns and shares voting and dispositive power with respect to all of the securities owned by HCVIX, and each disclaimed beneficial ownership of the warrants except to the extent of his or its proportionate pecuniary interest therein.
- [F3]The warrants were acquired in connection with the purchase of an equal number of shares of common stock by the reporting persons on February 5, 2019 for $1.75 per share. Each such purchased share of common stock was issued with a warrant to purchase one share of common stock. HCVIX will continue to hold 4,144,804 shares of common stock following the Transfer.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001490245
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 9:57 PM ET
- Size
- 11.2 KB